• 1

    Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, Manlan K, Dri-Yoman T, Salamon R, 1999. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353 :1463–1468.

    • Search Google Scholar
    • Export Citation
  • 2

    Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, Yapi A, Combe P, Tossou O, Roels TH, Lackritz EM, Coulibaly D, De CK, Coulibaly IM, Greenberg AE, 1999. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d’Ivoire: a randomised controlled trial. Lancet 353 :1469–1475.

    • Search Google Scholar
    • Export Citation
  • 3

    Boeree MJ, Harries AD, Zijlstra EE, Taylor TE, Molyneux ME, 1999. Co-trimoxazole in HIV-1 infection. Lancet 354 :334.

  • 4

    van Oosterhout JJ, Laufer MK, Graham SM, Thumba F, Perez MA, Chimbiya N, Wilson L, Chagomerana M, Molyneux ME, Zijlstra EE, Taylor TE, Plowe CV, 2005. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV 2. J Acquir Immune Defic Syndr 39 :626–631.

    • Search Google Scholar
    • Export Citation
  • 5

    Whitty CJ, Jaffar S, 2002. Plasmodium falciparum cross resistance. Lancet 359 :80.

  • 6

    Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Farrelly L, Kaganson N, Zumla A, Gillespie SH, Nunn AJ, Gibb DM, 2004. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 364 :1865–1871.

    • Search Google Scholar
    • Export Citation
  • 7

    Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kigozi A, Nakanjako D, Wafula W, Quick R, 2004. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364 :1428–1434.

    • Search Google Scholar
    • Export Citation
  • 8

    Triglia T, Menting JGT, Wilson C, Cowman AF, 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94 :13944–13949.

    • Search Google Scholar
    • Export Citation
  • 9

    Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV, 2001. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358 :1066–1067.

    • Search Google Scholar
    • Export Citation
  • 10

    Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, Cissoko Y, Kone A, Guindo A, Dicko A, Beavogui AH, Djimde AA, Lyke KE, Diallo DA, Doumbo OK, Plowe CV, 2005. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 192 :1823–1829.

    • Search Google Scholar
    • Export Citation
  • 11

    Malamba S, Mermin J, Reingold A, Lule J, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G, 2006. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)–infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 75 :375–380.

    • Search Google Scholar
    • Export Citation
  • 12

    Lule JR, Mermin J, Ekwaru JP, Malamba S, Downing R, Ransom R, Nakanjako D, Wafula W, Hughes P, Bunnell R, Kaharuza F, Coutinho A, Kigozi A, Quick R, 2005. Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg 73 :926–933.

    • Search Google Scholar
    • Export Citation
 
 
 

 

 
 
 

 

 

 

 

 

 

COTRIMOXAZOLE PROPHYLAXIS AND MALARIA IN AFRICA: HAVE THE IMPORTANT QUESTIONS BEEN ANSWERED?

View More View Less
  • 1 University of Maryland School of Medicine, Baltimore, Maryland
Save